Isthmus Partners, LLC Cidara Therapeutics, Inc. Transaction History

Isthmus Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$1.48 - $2.35 $2,960 - $4,700	-2,000 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$1.87 - $2.7 $3,740 - $5,400	2,000 New	2,000 $4,000
Q4 2018 Feb 04, 2019	SELL	$2.1 - $4.5 $4,200 - $9,000	-2,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$4.0 - $8.15 $8,000 - $16,300	2,000 New	2,000 $8,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Isthmus Partners, LLC with notifications on news.